iShares IV plc MSCI China A UCITS ETF (IASH)
0.20p
(0.06%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.20p
(0.06%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.20p
(0.06%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
340.40p
341.40p
438.50p
London
340.25p
339.96p
288.90p
$3021.18M
1.05p (0.31%) Previous:
1.05p
35,023
n/a
GBX
ETP Basics
| Issuer: | n/a |
|---|---|
| Structure: | n/a |
| Replication method: | n/a |
| Securities lending: | No |
| Number of holdings: | 506 |
| Size: | $3021.2M |
| Launch date: | 08 April 2015 |
| Launch price: | n/a |
| UCITS: | n/a |
| Reporting status: | n/a |
| Domicile: | Ireland |
| Complex product: | Non-complex |
| ISIN: | IE00BQT3WG13 |
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website for more information.
Annual & interim reports
Before you invest, please make sure you read the documents below
What is a Value Assessment?
Fund Managers are required to regularly assess whether the fund they manage delivers value to investors. When completing their assessment, they will consider investment performance, service offered, costs and charges, and competitor funds. The Assessment of Value for funds is subject to the Financial Conduct Authority's Collective Investment Scheme (COLL) rules or a Price and Value Assessment (PRIN) for other funds not subject to COLL rules.
Why it matters to investors?
The Value Assessment helps an investor understand how a Fund Manager has considered how their fund has delivered value for money or is expected to deliver value for money. The Fund Manager will explain the actions they are taking if their fund has not delivered value for money or it is not expected to deliver value for money.
Value Assessment
| Value Assessment review date: | 30 September 2024 |
|---|---|
| Value Assessment next review date: | - |
| Is Assessment of Value required under COLL: | No |
| Outcome of COLL Assessment of Value: | n/a |
| Outcome of PRIN Value Assessment or review: | Product expected to provide fair value for reasonably foreseeable period |
| Other review related to value and or charges: | - |
| Further information: | - |
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | MSCI China A International index |
|---|---|
| Aim: |
The Share Class is a share class of a Fund which aims to achieve a return on your...
Read full aim for iShares IV plc |
| Leverage: | n/a |
| Currency hedging: | n/a |
COSTS
| Ongoing Charge (OCF/TER): | 0.40% |
|---|---|
| Management fee: | n/a |
| Indicative spread: | 0.09% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
| Security | Weight |
|---|---|
| KWEICHOW MOUTAI GROUP CO. LTD | 5.69% |
| CONTEMPORARY AMPEREX TECHNOLOGY CO | 2.61% |
| CHINA MERCHANTS BANK CO. | 1.79% |
| YIBIN WULIANGYE | 1.68% |
| PING AN INSURANCE (GROUP) COMPANY OF CHINA | 1.45% |
| CHINA YANGTZE POWER CO. | 1.28% |
| BYD CO. | 1.20% |
| SHENZHEN MINDRAY BIO MEDICAL ELE CO | 0.97% |
| INDUSTRIAL BANK CO LTD | 0.92% |
| LUZHOU OLD CELLAR | 0.85% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.